Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBIVAR: Varenicline plus Nicotine Patches for Smoking Cessation
NCT01538394Phase 4Completed
- Start
- Jan 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in tobacco dependence comparing Varenicline & nicotine patches with Varenicline & placebo patches (2 arms). Primary endpoint: Continuous Abstinence Rate at 12 weeks. Started Jan 2012; status: completed.
02
Drugs
nicotine
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT01538394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01538394.